Research into conolidine has triggered discovery of an opioid receptor in the human body called ACKR3/CXCR7. ACKR3 seems to be by far the most popular target for conolidine, which also disregards the opposite four classical opioid receptors(three). Sign in like a member to understand when there is clinical proof https://ricardoakopq.bloggip.com/37950976/new-step-by-step-map-for-conolidin-to-replace-traditional-painkillers